-

Seek Labs Appoints Kim Wirthlin as Chief Strategy Officer

SALT LAKE CITY--(BUSINESS WIRE)--Seek Labs, a healthcare innovations company developing diagnostic and therapeutic solutions that have the potential to revolutionize the detection and treatment of diseases, is pleased to announce the appointment of Kim Wirthlin as Chief Strategy Officer, effective March 17, 2025. Wirthlin brings more than 25 years of experience in university leadership, government relations, academic healthcare, and early-stage company development. As Chief Strategy Officer, Wirthlin will lead Seek Labs’ strategic initiatives, strengthening partnerships and expanding the company’s influence as global healthcare innovators.

As Chief Strategy Officer, Wirthlin will lead Seek Labs’ strategic initiatives, strengthening partnerships and expanding the company’s influence as global healthcare innovators.

Share

Prior to joining Seek Labs, Wirthlin served as President and COO of the Huntsman Cancer Foundation, where she led philanthropic strategies that supported groundbreaking cancer research and advanced clinical care. Prior to that, she spent 18 years as a member of the executive management team at University of Utah Health, where she solidified her reputation as a strong strategist in higher education and healthcare.

“Kim’s deep expertise in healthcare strategy, government affairs, and early-stage company growth will be instrumental in driving Seek Labs through our next phase of innovation and expansion,” said Jared Bauer, CEO of Seek Labs. “I am confident her leadership and insight will enhance our strategic initiatives as we continue to develop cutting-edge diagnostic and therapeutic solutions.”

Beyond her extensive work in academia and healthcare, Wirthlin has actively contributed to the start-up ecosystem as a mentor, advisor, and board member for emerging healthcare companies. She also served as CEO for two early-stage companies, bringing hands-on experience in scaling innovative ventures. In addition to her professional achievements, Wirthlin is deeply engaged in community service. She previously served as board chair for the Fourth Street Clinic, a healthcare provider for individuals experiencing homelessness. She continues to serve on the Fourth Street Clinic’s capital campaign committee and is an executive committee member of the International Women’s Forum.

“I’m honored to join Seek Labs at such a pivotal time in its growth,” said Wirthlin. “The company’s mission to transform healthcare through innovation aligns with my passion for bringing accessible and transformative healthcare solutions to people around the world. I look forward to contributing to Seek Labs’ vision and impact.”

About Seek Labs

Seek Labs is a privately held biotechnology company founded in 2016 and based in Salt Lake City, Utah. The company is dedicated to advancing research and solutions aimed at improving global health. Today, Seek Labs is developing point-of-care molecular diagnostic technologies and programmable target ablation therapeutics designed to transform disease detection and treatment. Seek Labs is a proud member of the BioHive, a collective representing the life sciences and healthcare innovation ecosystem in Utah.

Contacts

Bridget Baldwin
Director of Communications, Seek Labs
communications@seeklabs.com

More News From Seek Labs

Seek Labs Publishes First Peer-Reviewed Paper Demonstrating A CRISPR-Based Therapeutic Is Effective Against African Swine Fever

SALT LAKE CITY--(BUSINESS WIRE)--Seek Labs, a biotechnology company boldly seeking a healthier world through AI-powered discovery, programmable therapeutics, and point-of-care diagnostics, today announced the publication of a peer-reviewed paper in Viruses (MDPI), revealing the first successful use of a CRISPR-based therapeutic to treat African Swine Fever Virus (ASFV) in pigs. The findings demonstrate the company’s proprietary CRISPR-based therapeutic successfully reduced viremia, enabling rec...

Seek Labs Expands Global Disease Atlas with Mapping of Hemorrhagic Fever Viruses through BioSeeker™

SALT LAKE CITY--(BUSINESS WIRE)--Seek Labs, a biotech company boldly seeking a healthier world through AI-powered discovery programmable therapeutics, and point-of-care diagnostics, today announced an expansion of its Global Disease Atlas™ to include multiple hemorrhagic fever viruses. BioSeeker™, the company’s AI-powered discovery engine, has completed comprehensive genomic mapping across a suite of high-priority hemorrhagic fever viruses (HFV), which include Ebola virus, Marburg virus, Lassa...

Seek Labs Advances Development of Pan-Orthopoxvirus Therapeutic with BioSeeker™ and PTAP™

SALT LAKE CITY--(BUSINESS WIRE)--Seek Labs, a biotech company boldly seeking a healthier world through AI-powered discovery, programmable therapeutics, and point-of-care diagnostics, today announced progress toward developing the world’s first pan-orthopoxvirus therapeutic, a breakthrough with significant implications for global health security. Orthopoxviruses are part of a group of double-stranded DNA viruses in the Poxviridae family that infect mammals, which include subtypes like human smal...
Back to Newsroom